Bingham Osborn & Scarborough’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,566
Closed -$600K 2
2021
Q3
$600K Sell
5,566
-775
-12% -$83.5K 0.04% 73
2021
Q2
$714K Buy
6,341
+1,064
+20% +$120K 0.05% 65
2021
Q1
$571K Buy
5,277
+148
+3% +$16K 0.04% 70
2020
Q4
$550K Sell
5,129
-14,044
-73% -$1.51M 0.04% 65
2020
Q3
$1.68M Buy
19,173
+229
+1% +$20.1K 0.13% 46
2020
Q2
$1.86M Sell
18,944
-1,260
-6% -$124K 0.15% 40
2020
Q1
$1.54M Sell
20,204
-2,652
-12% -$202K 0.15% 40
2019
Q4
$2.02M Buy
22,856
+171
+0.8% +$15.1K 0.17% 37
2019
Q3
$1.72M Sell
22,685
-43
-0.2% -$3.26K 0.15% 37
2019
Q2
$1.65M Sell
22,728
-1,193
-5% -$86.8K 0.15% 35
2019
Q1
$1.93M Sell
23,921
-1,170
-5% -$94.3K 0.18% 34
2018
Q4
$2.31M Buy
25,091
+507
+2% +$46.7K 0.24% 30
2018
Q3
$2.33M Sell
24,584
-2,975
-11% -$281K 0.21% 34
2018
Q2
$2.55M Sell
27,559
-7,602
-22% -$704K 0.24% 33
2018
Q1
$3.33M Buy
35,161
+3,886
+12% +$368K 0.31% 27
2017
Q4
$3.03M Buy
31,275
+10,207
+48% +$987K 0.28% 27
2017
Q3
$1.87M Sell
21,068
-51
-0.2% -$4.53K 0.18% 33
2017
Q2
$1.53M Buy
21,119
+1,754
+9% +$127K 0.15% 33
2017
Q1
$1.26M Buy
19,365
+1,237
+7% +$80.6K 0.12% 36
2016
Q4
$1.14M Sell
18,128
-853
-4% -$53.4K 0.12% 38
2016
Q3
$1.2M Buy
18,981
+476
+3% +$30K 0.13% 39
2016
Q2
$1.15M Buy
18,505
+114
+0.6% +$7.06K 0.13% 39
2016
Q1
$1.05M Buy
18,391
+89
+0.5% +$5.09K 0.12% 40
2015
Q4
$1.08M Sell
18,302
-358
-2% -$21.2K 0.13% 41
2015
Q3
$1.02M Buy
18,660
+3,297
+21% +$179K 0.13% 41
2015
Q2
$1.03M Buy
15,363
+121
+0.8% +$8.13K 0.12% 38
2015
Q1
$892K Hold
15,242
0.11% 43
2014
Q4
$997K Sell
15,242
-64
-0.4% -$4.19K 0.12% 41
2014
Q3
$884K Hold
15,306
0.11% 42
2014
Q2
$864K Sell
15,306
-138
-0.9% -$7.79K 0.11% 37
2014
Q1
$794K Sell
15,444
-650
-4% -$33.4K 0.11% 39
2013
Q4
$850K Buy
16,094
+752
+5% +$39.7K 0.12% 37
2013
Q3
$686K Buy
15,342
+1,367
+10% +$61.1K 0.11% 44
2013
Q2
$578K Buy
+13,975
New +$578K 0.1% 44